Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The Growth-Arrest-Specific (GAS)-5 Long Non-Coding RNA: A Fascinating lncRNA Widely Expressed in Cancers.

Goustin AS, Thepsuwan P, Kosir MA, Lipovich L.

Noncoding RNA. 2019 Sep 17;5(3). pii: E46. doi: 10.3390/ncrna5030046. Review.

2.

Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.

Lin CY, Kleinbrink EL, Dachet F, Cai J, Ju D, Goldstone A, Wood EJ, Liu K, Jia H, Goustin AS, Kosir MA, Thepsuwan P, Lipovich L.

Open Biol. 2016 Dec;6(12). pii: 150262. doi: 10.1098/rsob.150262.

3.

Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor.

Goustin AS, Derar N, Abou-Samra AB.

Cell Signal. 2013 Apr;25(4):981-8. doi: 10.1016/j.cellsig.2012.12.011. Epub 2013 Jan 11.

PMID:
23314177
4.

The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance.

Goustin AS, Abou-Samra AB.

Cell Signal. 2011 Jun;23(6):980-90. doi: 10.1016/j.cellsig.2010.11.003. Epub 2010 Nov 16. Review.

PMID:
21087662
5.

Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM.

Curr Cancer Drug Targets. 2010 May;10(3):319-31.

6.

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status.

Al-Katib AM, Sun Y, Goustin AS, Azmi AS, Chen B, Aboukameel A, Mohammad RM.

J Hematol Oncol. 2009 Feb 16;2:8. doi: 10.1186/1756-8722-2-8.

7.

Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.

Mohammad R, Giri A, Goustin AS.

Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):20-30. Review.

PMID:
18289121
8.

Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.

Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A.

Clin Cancer Res. 2007 Apr 1;13(7):2226-35.

9.

Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cells.

Hamdy N, Goustin AS, Desaulniers JP, Li M, Chow CS, Al-Katib A.

J Immunol Methods. 2005 Feb;297(1-2):109-24. Epub 2005 Jan 11.

PMID:
15777935
10.

Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA.

Mol Cell Biol. 2003 May;23(9):3173-85.

11.

Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene.

Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G.

Diabetes. 2002 Aug;51(8):2450-8.

Supplemental Content

Loading ...
Support Center